课题基金 / 基金详情

Toward personalized immunotherapy: identifying tumour-specific factors that dictate the response of spontaneous mammary cancers to T cells

Toward personalized immunotherapy: identifying tumour-specific factors that dictate the response of spontaneous mammary cancers to T cells
迈向个性化免疫治疗:确定决定自发性乳腺癌对 T 细胞反应的肿瘤特异性因素
批准号:
201101
负责人:
Nelson Brad H
金额:
$48.95万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-03-01 至 2015-03-01

项目摘要

项目成果

Nelson Brad H的其他基金

相似基金

相关文献

中文摘要
翻译
这项拟议中的研究将研究免疫系统如何对乳腺癌做出反应,以及如何最好地操纵免疫反应来治疗已建立的肿瘤。我们的研究小组开发了一种转基因小鼠乳腺癌模型,
英文摘要
The proposed research will investigate how the immune system responds to breast cancer, and how best to manipulate the immune response to treat established tumors. Our group developed a transgenic mouse model of breast cancer, in which mice develop sponta
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the Hottest Immune Neighbourhoods in Ovarian Cancer to Advance Immunotherapy
  • 批准号:
    469224
  • 项目类别:
    Operating Grants
  • 资助金额:
    $71.61万
  • 财政年份:
    2022
  • 负责人:
    Nelson Brad H
  • 依托单位:
Mechanisms of B cell-mediated immunity in human cancer
  • 批准号:
    409891
  • 项目类别:
    Operating Grants
  • 资助金额:
    $86.94万
  • 财政年份:
    2019
  • 负责人:
    Nelson Brad H
  • 依托单位:
Joint Meeting of the Canadian Cancer Immunotherapy Consortium and ImmunoBC 2018
  • 批准号:
    383765
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2018
  • 负责人:
    Nelson Brad H
  • 依托单位:
Mechanisms of Protective Immunity in Ovarian Cancer
  • 批准号:
    321860
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.59万
  • 财政年份:
    2015
  • 负责人:
    Nelson Brad H
  • 依托单位:
海外基金